ALLMedicine™ Lung Cancer Center
Research & Reviews 105,123 results
https://doi.org/10.1186/s12904-021-00731-4 10.3109/02841861003782017 10.1002/ijc.29210 10.1200/JCO.2010.31.9897 10.1093/intqhc/mzw060 10.1200/JCO.2010.32.4459 10.1002/cncr.29250 10.1002/jmrs.188 10.1038/bjc.2013.585 10.1080/0284186X.2017.1279748 10.1200/JCO.2005.03.3027 10.1016/j.lungcan.2003.09.001 10.1054/bjoc.2000.1307 10.1016/j.jgo.2014.04.002 10.1002/cncr.11548 10.1016/S0959-8049(00)00169-6 10.1016/j.jbi.2019.103208 10.1016/j.jbi.2008.08.010 10.1002/nur.20195 10.1200/JCO.1993.11.3.570 10.1023/A:1015276414526 10.1007/BF00433916 10.1186/1471-2407-13-66 10.1016/j.jpainsymman.2018.09.014 10.1038/sj.bjc.6604395 10.1634/theoncologist.2018-0890
BMC Palliative Care; Ikander T, Jeppesen SS et. al.
Feb 27th, 2021 - When discussing treatment options and future care, it is important to understand the expectations of patients and family caregivers related to palliative chemotherapy and to identify patterns in patients' quality of life. The study aims were to ev...
https://doi.org/10.1186/s12957-021-02161-1 10.3322/caac.21262 10.3322/caac.21492 10.1126/science.1104819 10.1016/S0065-230X(08)60946-X 10.1200/jco.2004.22.90140.2542 10.1016/0197-2456(95)00134-4 10.1007/s10654-010-9491-z 10.1136/bmj.316.7124.61 10.1515/med-2018-0022 10.1016/j.cllc.2013.12.006
World Journal of Surgical Oncology; Feng L, Wang Z et. al.
Feb 27th, 2021 - This paper aims to compare the efficacy and safety of recombinant human endostatin combined with chemotherapy in patients with squamous cell lung cancer (SqCLC). We searched the Cochrane Library, PubMed, Embase, CNKI, Wanfang database, Metstr, VIP...
https://doi.org/10.1016/j.cllc.2021.01.006
Clinical Lung Cancer; Keiser MF, Patel AB et. al.
Feb 27th, 2021 - Immune checkpoint inhibitors (ICPIs) have transformed the treatment of lung cancer in the recent years. However, disruption in immune homeostasis produces a unique spectrum of side effects termed as immune-related adverse events (irAEs). Cutaneous...
https://doi.org/10.1002/pon.5650
Psycho-oncology McLouth LE, Weyman K et. al.
Feb 27th, 2021 - Between 40% and 65% of lung cancer patients report concern about maintaining valued activities and roles, yet few interventions address this concern. Hope, a patient's perceived ability to generate goals and identify ways to pursue them, may be a ...
https://doi.org/10.1007/s40265-021-01477-2 10.1016/j.ccm.2011.09.001 10.1038/nrc.2017.84 10.1200/JCO.2015.63.4600 10.3978/j.issn.2218-6751.2012.09.03 10.2741/2760 10.1007/BF00204976 10.1073/pnas.94.21.11445 10.3978/j.issn.2218-6751.2015.03.05 10.1158/2159-8290.CD-19-1446 10.1083/jcb.153.5.1023 10.1158/0008-5472.CAN-05-4422 10.1016/j.jtho.2016.10.014 10.3978/j.issn.2305-5839.2015.03.58 10.1038/nrm1261 10.1200/JCO.2012.47.4189 10.1200/JCO.2016.69.2160 10.1586/14737140.2015.1031219 10.1200/JCO.2014.60.7317 10.1126/science.1141478 10.1016/j.jtho.2016.04.033 10.21037/tlcr-19-339 10.1158/0008-5472.CAN-06-3495 10.1016/j.jtho.2016.09.116 10.1056/NEJMoa2002787 10.1038/sj.onc.1209717 10.1016/j.jtho.2016.06.013 10.1158/2159-8290.CD-15-0285 10.1038/nature13385 10.1158/2159-8290.CD-14-1467 10.1634/theoncologist.2015-0510 10.1097/JTO.0000000000000478 10.1016/j.cllc.2015.01.009 10.1200/JCO.2016.34.15_suppl.108 10.1016/j.ctrv.2020.102022 10.1097/JTO.0000000000000491 10.1038/s41591-019-0716-8 10.1016/j.lungcan.2016.05.015 10.1158/1078-0432.CCR-19-3608 10.1158/1078-0432.CCR-11-1157 10.1200/JCO.2016.34.15_suppl.9067 10.1016/j.annonc.2020.03.293 10.1007/s40265-020-01347-3 10.1200/JCO.2018.36.15_suppl.9016 10.1056/NEJMoa2004407 10.1007/s40265-020-01317-9 10.1158/1538-7445.Am2016-1150 10.1200/JCO.2020.38.15_suppl.9519 10.1016/S1470-2045(19)30785-5 10.1016/j.jtho.2017.09.377 10.1186/s13045-019-0759-9 10.1016/j.jtho.2016.09.127 10.1016/S1470-2045(16)30561-7 10.1038/emm.2017.17 10.3390/biomedicines3010149 10.1158/1078-0432.Ccr-16-1568 10.1158/1078-0432.Ccr-14-0543 10.1158/1538-7445.Am2017-519 10.1158/1078-0432.Ccr-16-1418 10.1016/j.jtho.2019.10.003 10.1158/1535-7163.Targ-09-c181 10.1200/jco.2010.28.15_suppl.2525 10.1002/cpdd.427 10.1016/j.jtho.2017.09.458 10.1200/jco.2018.78.7697
Drugs Garon EB, Brodrick P
Feb 27th, 2021 - The tyrosine kinase receptor mesenchymal epithelial transition (MET) is a proto-oncogene that, through the activation of the MET-hepatocyte growth factor (HGF) pathway, encodes a variety of biological processes, including cell development, prolife...
Guidelines 587 results
https://academic.oup.com/jncics/article/4/4/pkaa055/5894724?searchresult=1
JNCI Cancer Spectrum; Jemal A
Aug 19th, 2020 - We previously reported that lung cancer incidence between Blacks and Whites younger than 40 years of age converged in women and approached convergence in men. Whether this pattern has continued in contemporary young birth cohorts is unclear.
https://pubmed.ncbi.nlm.nih.gov/32746691/
Journal of Oncology Pharmacy Practice; Rosentreter J
Aug 2nd, 2020 - Cancer patients tend to prefer oral instead of parenteral chemotherapy. To date, there is little evidence on the medication adherence in cancer patients. We investigated medication adherence to tyrosine kinase inhibitors in patients suffering from...
https://www.jto.org/article/S1556-0864(20)30595-5/pdf
Journal of Thoracic Oncology; Yang Y
Jul 24th, 2020 - Sintilimab, an anti-programmed death 1 antibody, plus pemetrexed and platinum had shown promising efficacy for nonsquamous non-small cell lung cancer in a phase 1b study. We conducted a randomized, double-blind, phase 3 study to compare the ef...
https://www.nature.com/articles/s41598-020-67378-8
Scientific Report; Perez-Morales J
Jun 28th, 2020 - The National Lung Screening Trial (NLST) demonstrated that screening with low-dose computed tomography (LDCT) is associated with a 20% reduction in lung cancer mortality. One potential limitation of LDCT screening is overdiagnosis of slow growing ...
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200223/full/
Jun 24th, 2020 - Although the ASCO Annual Meeting felt much different this year given the virtual format, the quality of research presented at the meeting was undiminished, particularly in the field of lung cancer. ASCO Daily News Expert Panel member Jared Weiss, ...
Drugs 391 results see all →
Clinicaltrials.gov 114,003 results
https://doi.org/10.1186/s12904-021-00731-4 10.3109/02841861003782017 10.1002/ijc.29210 10.1200/JCO.2010.31.9897 10.1093/intqhc/mzw060 10.1200/JCO.2010.32.4459 10.1002/cncr.29250 10.1002/jmrs.188 10.1038/bjc.2013.585 10.1080/0284186X.2017.1279748 10.1200/JCO.2005.03.3027 10.1016/j.lungcan.2003.09.001 10.1054/bjoc.2000.1307 10.1016/j.jgo.2014.04.002 10.1002/cncr.11548 10.1016/S0959-8049(00)00169-6 10.1016/j.jbi.2019.103208 10.1016/j.jbi.2008.08.010 10.1002/nur.20195 10.1200/JCO.1993.11.3.570 10.1023/A:1015276414526 10.1007/BF00433916 10.1186/1471-2407-13-66 10.1016/j.jpainsymman.2018.09.014 10.1038/sj.bjc.6604395 10.1634/theoncologist.2018-0890
BMC Palliative Care; Ikander T, Jeppesen SS et. al.
Feb 27th, 2021 - When discussing treatment options and future care, it is important to understand the expectations of patients and family caregivers related to palliative chemotherapy and to identify patterns in patients' quality of life. The study aims were to ev...
https://doi.org/10.1186/s12957-021-02161-1 10.3322/caac.21262 10.3322/caac.21492 10.1126/science.1104819 10.1016/S0065-230X(08)60946-X 10.1200/jco.2004.22.90140.2542 10.1016/0197-2456(95)00134-4 10.1007/s10654-010-9491-z 10.1136/bmj.316.7124.61 10.1515/med-2018-0022 10.1016/j.cllc.2013.12.006
World Journal of Surgical Oncology; Feng L, Wang Z et. al.
Feb 27th, 2021 - This paper aims to compare the efficacy and safety of recombinant human endostatin combined with chemotherapy in patients with squamous cell lung cancer (SqCLC). We searched the Cochrane Library, PubMed, Embase, CNKI, Wanfang database, Metstr, VIP...
https://doi.org/10.1016/j.cllc.2021.01.006
Clinical Lung Cancer; Keiser MF, Patel AB et. al.
Feb 27th, 2021 - Immune checkpoint inhibitors (ICPIs) have transformed the treatment of lung cancer in the recent years. However, disruption in immune homeostasis produces a unique spectrum of side effects termed as immune-related adverse events (irAEs). Cutaneous...
https://doi.org/10.1002/pon.5650
Psycho-oncology McLouth LE, Weyman K et. al.
Feb 27th, 2021 - Between 40% and 65% of lung cancer patients report concern about maintaining valued activities and roles, yet few interventions address this concern. Hope, a patient's perceived ability to generate goals and identify ways to pursue them, may be a ...
https://doi.org/10.1007/s40265-021-01477-2 10.1016/j.ccm.2011.09.001 10.1038/nrc.2017.84 10.1200/JCO.2015.63.4600 10.3978/j.issn.2218-6751.2012.09.03 10.2741/2760 10.1007/BF00204976 10.1073/pnas.94.21.11445 10.3978/j.issn.2218-6751.2015.03.05 10.1158/2159-8290.CD-19-1446 10.1083/jcb.153.5.1023 10.1158/0008-5472.CAN-05-4422 10.1016/j.jtho.2016.10.014 10.3978/j.issn.2305-5839.2015.03.58 10.1038/nrm1261 10.1200/JCO.2012.47.4189 10.1200/JCO.2016.69.2160 10.1586/14737140.2015.1031219 10.1200/JCO.2014.60.7317 10.1126/science.1141478 10.1016/j.jtho.2016.04.033 10.21037/tlcr-19-339 10.1158/0008-5472.CAN-06-3495 10.1016/j.jtho.2016.09.116 10.1056/NEJMoa2002787 10.1038/sj.onc.1209717 10.1016/j.jtho.2016.06.013 10.1158/2159-8290.CD-15-0285 10.1038/nature13385 10.1158/2159-8290.CD-14-1467 10.1634/theoncologist.2015-0510 10.1097/JTO.0000000000000478 10.1016/j.cllc.2015.01.009 10.1200/JCO.2016.34.15_suppl.108 10.1016/j.ctrv.2020.102022 10.1097/JTO.0000000000000491 10.1038/s41591-019-0716-8 10.1016/j.lungcan.2016.05.015 10.1158/1078-0432.CCR-19-3608 10.1158/1078-0432.CCR-11-1157 10.1200/JCO.2016.34.15_suppl.9067 10.1016/j.annonc.2020.03.293 10.1007/s40265-020-01347-3 10.1200/JCO.2018.36.15_suppl.9016 10.1056/NEJMoa2004407 10.1007/s40265-020-01317-9 10.1158/1538-7445.Am2016-1150 10.1200/JCO.2020.38.15_suppl.9519 10.1016/S1470-2045(19)30785-5 10.1016/j.jtho.2017.09.377 10.1186/s13045-019-0759-9 10.1016/j.jtho.2016.09.127 10.1016/S1470-2045(16)30561-7 10.1038/emm.2017.17 10.3390/biomedicines3010149 10.1158/1078-0432.Ccr-16-1568 10.1158/1078-0432.Ccr-14-0543 10.1158/1538-7445.Am2017-519 10.1158/1078-0432.Ccr-16-1418 10.1016/j.jtho.2019.10.003 10.1158/1535-7163.Targ-09-c181 10.1200/jco.2010.28.15_suppl.2525 10.1002/cpdd.427 10.1016/j.jtho.2017.09.458 10.1200/jco.2018.78.7697
Drugs Garon EB, Brodrick P
Feb 27th, 2021 - The tyrosine kinase receptor mesenchymal epithelial transition (MET) is a proto-oncogene that, through the activation of the MET-hepatocyte growth factor (HGF) pathway, encodes a variety of biological processes, including cell development, prolife...
News 7,181 results
https://www.medscape.com/viewarticle/946366
Feb 23rd, 2021 - The US Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) for the treatment of advanced non–small cell lung cancer (NSCLC). Specifically, the indication is for first-line treatment as monotherapy for patients with locally ad...
https://www.medscape.com/viewarticle/946293
Feb 22nd, 2021 - After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be withdrawn in the United States for the immunotherapy durvalumab (Imfinzi), AstraZeneca announced. The withdrawal does n...
https://www.medscape.com/viewarticle/946288
Feb 22nd, 2021 - Cancer death rates overall continue to fall among both men and women in Europe, with the notable exception of pancreatic cancer in both sexes and lung cancer among women living in the European Union, notes an update report. "Among the major cancer...
https://www.medscape.com/viewarticle/946034
Feb 17th, 2021 - Artificial intelligence (AI) is expected to one day affect the entire continuum of cancer care – from screening and risk prediction to diagnosis, risk stratification, treatment selection, and follow-up, according to an expert in the field. Hugo J....
https://www.medscape.com/viewarticle/946016
Feb 16th, 2021 - Feb. 17, 2021 — Rush Limbaugh, for decades a popular, controversial, and influential talk radio host and conservative commentator, died Wednesday, according to a family statement. He was 70.